You may also like
Investigation of Myocardial Protection During Pediatric CPB: Practical Experience in 100 Chinese Hospitals
In conclusion, the essence of myocardial protection management during pediatric CPB was cardiac arrest induced by cardioplegia under systemic hypothermia. However, there is no uniform standard for the type of cardioplegia, or dosages. Therefore, well-designed multicenter randomized controlled trials are warranted to provide tangible evidence for myocardial protection of cardioplegia in pediatric CPB.
1 min read
Prolonged Venovenous Extracorporeal Membrane Oxygenation Without Anticoagulation: A Case of Goodpasture Syndrome-Related Pulmonary Haemorrhage
We present a 16-year-old male with severe acute respiratory and renal failure as a result of Goodpasture syndrome, requiring venovenous extracorporeal membrane oxygenation (VV-ECMO) for pulmonary haemorrhage. The patient received no systemic anticoagulation for 25 of 26 ECMO days (20 days consecutively) and suffered no coagulation-related adverse events.
1 min read
Managing the Coagulopathy Associated with Cardiopulmonary Bypass.
While challenging, the effective management of CPB‐associated coagulopathy can significantly improve patient outcomes.
1 min read